Mesoblast Limited Recorded Big Gain
Wed, Mar 08, 2023 at 08:07 PM
Mesoblast Limited (MESO:NASDAQ) rocketted at $3.75, a gain of 23.8%. On Wed, Mar 08, 2023, MESO:NASDAQ hit a New 2-Week High of $3.75. The stock appeared on our News Catalysts scanner on Wed, Mar 08, 2023 at 12:50 PM in the 'BIOTECH' category. From Wed, Feb 22, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About Mesoblast Limited (MESO:NASDAQ)
Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells.
Top 10 Gainers:
- Kimball International, Inc. (KBAL:NASDAQ), 84.35%
- Castor Maritime Inc. (CTRM:NASDAQ), 77.9%
- Arlo Technologies, Inc. (ARLO:NYSE), 50.14%
- Maxeon Solar Technologies Ltd. (MAXN:NASDAQ), 44%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Diversey Holdings Ltd. (DSEY:NASDAQ), 37.48%
- Top Ships Inc. (TOPS:NASDAQ), 29.63%
- ObsEva SA (OBSV:NASDAQ), 27.86%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 25.58%
- Mesoblast Limited (MESO:NASDAQ), 23.76%